类A拾尸体受体MARCO负面调节ACE表达和阿尔多的生产
Conan J O O'Brien1, Giorgio Ratti1, Hellen Veida-Silva1,2
1Department of Physiology, Anatomy, & Genetics, University of Oxford, Oxford, United Kingdom.
eLife
|December 24, 2025
概括
在雄性小鼠中,表达清洁者受体 MARCO 的膜巨细胞降低了 aldosterone 生产和血管素转化酶 (Ace) 表达. 这揭示了免疫和内分泌系统在血压调节中的新联系.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 心血管生理学心血管生理学
背景情况:
- 阿尔多是一个由胆固醇衍生的类固醇激素,通过控制血液体积,对血压调节至关重要.
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 涉及上腺,脏和肺部,通常控制阿尔多斯特的释放.
研究的目的:
- 研究食受体MARCO在膜巨细胞上表达的作用,调节阿尔多素的产生.
- 在血压控制的背景下,探索免疫系统和内分泌系统之间的相互作用.
主要方法:
- 在膜巨细胞上对食尸体受体MARCO的表达分析.
- 在雄性小鼠中评估阿尔多斯特的产生.
- 在肺组织中测量血管氨酸转化酶 (Ace) 表达.
主要成果:
- 发现表达MARCO的膜巨细胞对阿尔多素的产生产生产生了负面调节.
- 在雄性小鼠的肺部中,膜巨细胞中MARCO的表达抑制了血管酶转化酶 (Ace) 的表达.
结论:
- 膜巨细胞被确定为renin-angiotensin-aldosterone系统中的新参与者.
- 描述了一种影响血压的免疫和内分泌系统相互作用的新机制.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Antihypertensive Drugs: Action of β1 Blockers
1.8K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.8K
Adrenergic Receptors: ɑ Subtype
2.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.6K


